Skip to main content

Ethics and Policy for Bioprinting

  • Protocol
  • First Online:
3D Bioprinting

Part of the book series: Methods in Molecular Biology ((MIMB,volume 2140))

Abstract

3D bioprinting involves engineering live cells into a 3D structure, using a 3D printer to print cells, often together with a compatible 3D scaffold. 3D-printed cells and tissues may be used for a range of purposes including medical research, in vitro drug testing, and in vivo transplantation. The inclusion of living cells and biomaterials in the 3D printing process raises ethical, policy, and regulatory issues at each stage of the bioprinting process that include the source of cells and materials, stability and biocompatibility of cells and materials, disposal of 3D-printed materials, intended use, and long-term effects. This chapter focuses on the ethical issues that arise from 3D bioprinting in the lab—from consideration of the source of cells and materials, ensuring their quality and safety, through to testing of bioprinted materials in animal and human trials. It also provides guidance on where to seek information concerning appropriate regulatory frameworks and guidelines, including on classification and patenting of 3D-bioprinted materials, and identifies regulatory gaps that deserve attention.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Murphy SV, Atala A (2014) 3D bioprinting of tissues and organs. Nat Biotechnol 32(8):773–785

    Article  CAS  PubMed  Google Scholar 

  2. Shafiee A, Atala A (2016) Printing technologies for medical applications. Trends Mol Med 22(3):254–265. https://doi.org/10.1016/j.molmed.2016.01.003

    Article  PubMed  Google Scholar 

  3. Baker HB, McQulling JP, King NM (2016) Ethical considerations in tissue engineering research: case studies in translation. Methods 99:135–144. https://doi.org/10.1016/j.ymeth.2015.08.010

    Article  CAS  PubMed  Google Scholar 

  4. Tuckson RV, Newcomer L, De Sa JM (2013) Accessing genomic medicine: affordability, diffusion, and disparities. JAMA 309(14):1469–1470

    Article  CAS  PubMed  Google Scholar 

  5. Allhoff F, Lin P, Steinberg J (2011) Ethics of human enhancement: an executive summary. Sci Eng Ethics 17:201–212. https://doi.org/10.1007/s11948-009-9191-9

    Article  PubMed  Google Scholar 

  6. Li P, Faulkner A (2017) 3D bioprinting regulations: a UK/EU perspective. Eur J Risk Regulat 8(2):441–447. https://doi.org/10.1017/err.2017.19

    Article  Google Scholar 

  7. National Health and Medical Research Council, Australian Research Council and Universities Australia (2007, Updated 2018) National Statement on ethical conduct in human research. Commonwealth of Australia, Canberra. https://www.nhmrc.gov.au/about-us/publications/national-statement-ethical-conduct-human-research-2007-updated-2018

  8. Wallace G, Cornock R, Connell C et al (2014) 3D bioprinting: printing parts for bodies. ARC Centre of Excellence for Electromaterials Science, Australia

    Google Scholar 

  9. World Medical Association (1964, updated 2013) World medical association declaration of Helsinki—ethical principles for medical research involving human subjects, J Am Med Assoc 310(20):2191–2194. https://doi.org/10.1001/jama.2013.281053. https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/

  10. Council for International Organizations of Medical Sciences and World Health Organization (1982, Updated 2016) international ethical guidelines for Health related research involving humans. 4th edition. CIOMS, Geneva. https://cioms.ch/wp-content/uploads/2017/01/WEB-CIOMS-EthicalGuidelines.pdf. Accessed 9 Aug 2019

  11. The Academy of Medical Sciences (2011) Animals Containing Human Material. https://acmedsci.ac.uk/file-download/35228-Animalsc.pdf. Accessed 9 Aug 2019

  12. Prohibition of Human Cloning for Reproduction Act 2002 (Cth). Australian Government. https://www.legislation.gov.au/Series/C2004A01081

  13. Leberfinger AN, Ravnic DJ, Dhawan A et al (2017) Concise review: bioprinting of stem cells for translatable tissue fabrication. Stem Cells Transl Med 6:1940–1948

    Article  PubMed  PubMed Central  Google Scholar 

  14. de Vries RBM, Oerlemans A, Trommelmans L et al (2008) Ethical aspects of tissue engineering: a review. Tissue Eng Part B Rev 14(4):367–375

    Article  PubMed  Google Scholar 

  15. de Wert G, Mummery C (2003) Human embryonic stem cells: research, ethics and policy. Hum Reprod 18(4):672–682

    Article  PubMed  Google Scholar 

  16. Klitzman R, Sauer MV (2015) Creating and selling embryos for “donation”: ethical challenges. Am J Obstet Gynecol 212(2):167–170. https://doi.org/10.1016/j.ajog.2014.10.1094

    Article  PubMed  Google Scholar 

  17. Research Involving Human Embryos Act 2002 (Cth). Australian Government. https://www.legislation.gov.au/Series/C2004A01082

  18. Advanced Human Fertilisation and Embryology Act (HFEA) 2008 (c22). http://www.legislation.gov.uk/ukpga/2008/22/contents

  19. Gilbert F, O’Connell CD, Mladenovska T et al (2018) Print me an organ? Ethical and regulatory issues emerging from 3D bioprinting in medicine. Sci Eng Ethics 24(1):73–91. https://doi.org/10.1007/s11948-017-9874-6

    Article  PubMed  Google Scholar 

  20. Vijayavenkataraman S, Lu WF, Fuh JYH (2016) 3D bioprinting—an ethical, legal and social aspects (ELSA) framework. Bioprinting 1–2:11–16

    Article  Google Scholar 

  21. Enoch S, Shaaban H, Dunn KW (2005) Informed consent should be obtained from patients to use products (skin substitutes) and dressing containing biological material. J Med Ethics 31(1):2–6

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. European Parliament and Council of the European Union European Tissues and Cells Directive, Directive 2004/23/EC. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=celex:32004L0023

  23. Human Tissue Act 2004, c. 30. https://www.legislation.gov.uk/ukpga/2004/30/contents

  24. Varkey M, Atala A (2015) Organ bioprinting: a closer look at ethics and policies. Wake Forest Journal of Law and Policy 275–298

    Google Scholar 

  25. Harbaugh JT (2015) Do you own your 3D bioprinted body? Analyzing property issues at the intersection of digital information and biology. Am J Law Med 41:167–189

    Article  PubMed  Google Scholar 

  26. National Institutes of Health (NIH) (2009) Guidelines on Human Stem Cell Research. https://stemcells.nih.gov/policy/2009-guidelines.htm

  27. Kantor J (2017) Public support in the U.S. for human-animal chimera research: results of a representative cross-sectional survey of 1,058 adults. Stem Cells Transl Med 6:1442–1444

    Article  PubMed  PubMed Central  Google Scholar 

  28. Koplin JJ, Savulescu J (2019) Time to re-think the law on part-human chimeras. J Law Biosci 6:37. https://doi.org/10.1093/jlb/lsz005

    Article  PubMed  PubMed Central  Google Scholar 

  29. Moy A (2017) Why the moratorium on human-animal chimera research should not be lifted. Linacre Quarterly 84:226–231

    Article  PubMed  PubMed Central  Google Scholar 

  30. World Health Organization, Laboratory Biosafety Manual 3rd Ed. https://www.who.int/csr/resources/publications/biosafety/WHO_CDS_CSR_LYO_2004_11/en/

  31. Bishop ES, Mostafe S, Pakvasa M et al (2017) 3-D bioprinting technologies in tissue engineering and regenerative medicine: Current and future trends. Genes Dis 4:185–195

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Mandrycky C, Wang Z, Kim K et al (2016) 3D bioprinting for engineering complex tissues. Biotechnol Adv 34(4):422–434

    Article  CAS  PubMed  Google Scholar 

  33. Office of the Federal Registrar, Code of Federal Regulations Title 21, Parts 1270 and 1271. US Government. https://www.ecfr.gov/cgi-bin/text-idx?SID=3ee286332416f26a91d9e6d786a604ab&mc=true&tpl=/ecfrbrowse/Title21/21tab_02.tpl

  34. World Health Organization (1997) Handbook: good laboratory practice (GLP): quality practices for regulated non-clinical research and development–2nd ed. https://www.who.int/tdr/publications/training-guidelinepublications/good-laboratory-practice-handbook/en/

  35. Office of the Federal Registrar Code of Federal Regulations, Title 21, Part 58. US government. https://www.ecfr.gov/cgi-bin/text-idx?SID=59467274f688447a894544906d008a39&mc=true&tpl=/ecfrbrowse/Title21/21tab_02.tpl

  36. OECD (1997) Principles of Good Laboratory Practice. http://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=env/mc/chem(98)17&doclanguage=en

  37. World Health Organization, Good Manufacturing Practices for Biological Products, Technical Report Series no 999, Annex 2. https://apps.who.int/medicinedocs/documents/s22400en/s22400en.pdf. Accessed 9 Aug 2019

  38. Office of the Federal Registrar (2011) Code of Federal Regulations, Title 21, Part 210 and 211. US Government

    Google Scholar 

  39. European Parliament and Council of the European Union, Commission directive 2003/94/EC of 8 October 2003 laying down the principles and guidelines of good manufacturing practice in respect of medicinal products for human use and investigational medicinal products for human use. https://ec.europa.eu/health/sites/health/files/files/eudralex/vol-1/dir_2003_94/dir_2003_94_en.pdf. Accessed 9 Aug 2019

  40. National Health and Medical Research Council NHRMC (2013) Australian code for the care and use of animals in research. Government of Australia, Canberra. https://nhmrc.gov.au/about-us/publications/australian-code-care-and-use-animals-scientific-purposes

    Google Scholar 

  41. Festing S, Wilkinson R (2007) The ethics of animal research. Talking Point on the use of animals in scientific research. EMBO Rep 8(6):526–530. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2002542/pdf/7400993.pdf

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. The Animals (Scientific Procedures) Act 1986. https://www.legislation.gov.uk/ukpga/1986/14/contents

  43. Animal Welfare Act of 1966 (AWA). https://www.gpo.gov/fdsys/pkg/USCODE-2015-title7/html/USCODE-2015-title7-chap54.htm

  44. Animal Welfare Regulations. https://www.gpo.gov/fdsys/pkg/CFR-2016-title9-vol1/xml/CFR-2016-title9-vol1-chapI-subchapA.xml

  45. European Parliament and Council of the European Union, Directive 210/63/EU on the protection of animals used for scientific purposes. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32010L0063

  46. Ogden BE, Wanyong P, Agui T et al (2016) Laboratory animal laws, regulations, guidelines and standards in China Mainland, Japan, and Korea. ILAR J 57(3):301–311. https://doi.org/10.1093/ilar/ilw018

    Article  CAS  PubMed  Google Scholar 

  47. European Parliament and Council of the European Union, Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices and Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices. https://ec.europa.eu/growth/sectors/medical-devices_en

  48. Hourd P et al (2015) 3D-bioprinting exemplar of the consequences of the regulatory requirement on customized process. Regen Med 10(7):863–883

    Article  CAS  PubMed  Google Scholar 

  49. Commonwealth of Australia (2018) Therapeutic Goods (Medical Devices) Regulations 2002. https://www.legislation.gov.au/Series/F2002B00237

  50. Commonwealth of Australia (July 2019) Commonwealth of Australia (July 2019) Therapeutic Goods Regulations (1990). https://www.legislation.gov.au/Series/F1996B00406

  51. Commonwealth of Australia (2011) Australian Regulatory Guidelines for Medical Devices. https://www.tga.gov.au/sites/default/files/devices-argmd-01.pdf Accessed 9 Aug 2019

  52. Commonwealth of Australia Australian Regulatory Guidelines for Biologicals. https://www.tga.gov.au/publication/australian-regulatory-guidelines-biologicals-argb

  53. European Parliament and Council of the European Union. Therapy Medicinal Products (ATMP) Regulation. Regulation (EC) No 1394/2007 of the European Parliament and the Council of 13 November 2007 on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004. https://ec.europa.eu/health//sites/health/files/files/eudralex/vol-1/reg_2007_1394/reg_2007_1394_en.pdf. Accessed 9 Aug 2019

  54. Li P (2014) 3D bioprinting technologies: patents, innovation and access. Law Innov Technol 6:282–304

    Article  Google Scholar 

  55. Bauer HKM, Heller M, Fink M et al (2016) Social and legal frame conditions for 3d (and) bioprinting in medicine. Int J Comput Dentist 19(4):293–299

    Google Scholar 

  56. Mendis D, Nielsen J, Nicol D et al (2017) The coexistence of copyright and patent laws to protect innovation: a case study of 3D printing in UK and Australian Law. The Oxford Handbook of Law, Regulation and Technology. Edited by R Brownsword, E Scotford, and K Yeung. doi: https://doi.org/10.1093/oxfordhb/9780199680832.013.80

  57. Tran JL (2015) To bioprint or not to bioprint. N C J Law Technol 17:123–178

    Google Scholar 

  58. Nielsen J, Nicol D (2019) The reform challenge: Australian patent law and the emergence of 3D printing. 3D printing and beyond: intellectual property and regulation. Edited by D Mendis, M Lemley and M Rimmer. Edward Elgar Publishing, Cheltenham, UK, pp 325–346

    Google Scholar 

  59. European Patent Convention (EPC), Article 53(a). https://www.epo.org/law-practice/legal-texts/html/epc/2016/e/ar53.html

  60. India, Patents Act, 1970, Chapter II, Section 3b (amendments). http://www.ipindia.nic.in/writereaddata/Portal/IPOAct/1_31_1_patent-act-1970-11march2015.pdf. Accessed 9 Aug 2019

Download references

Acknowledgments

The authors wish to acknowledge funding from the Australian Research Council (ARC) Centre of Excellence Scheme (CE140100012).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Eliza Goddard or Susan Dodds .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Goddard, E., Dodds, S. (2020). Ethics and Policy for Bioprinting. In: Crook, J.M. (eds) 3D Bioprinting. Methods in Molecular Biology, vol 2140. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0520-2_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-0716-0520-2_4

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-0716-0519-6

  • Online ISBN: 978-1-0716-0520-2

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics